| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3df8c441feb97cc4caf75a68370e6686
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e403d809a4fd37c338115a0264067c5 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B20-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B15-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B20-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B15-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B20-00 |
| filingDate |
2003-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8b8af0799233817d0b2b78d8d90ee98
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3057488151ad65e0fe1f51acbfd348fa |
| publicationDate |
2006-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2006111554-A1 |
| titleOfInvention |
Method, computing routine, device for predicting properties of mhc/peptide complexes, and data and peptides produced therefrom |
| abstract |
The present invention relates to a method for structure-based prediction of properties of peptides and peptide analogs in complex with major histocompatibility (MHC) class I and class II molecules. The said properties mainly relate to the three-dimensional structure of an MHC/peptide complex and the binding affinity of a peptide for an MHC receptor. The invention further relates to a computer program and a device therefor. The invention further relates to data produced by a method of the invention. The invention further relates to peptides and peptide analogs predicted to bind to target-MHC molecules. The present invention thus relates to the field of immunology, with possible applications in manufacture of vaccinates, de-immunization of proteins, and manufacture of therapeutic agents, especially immunotherapeutic agents. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8396671-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008021686-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011119484-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020123302-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7894995-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8706421-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8121797-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007192033-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007192039-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007192037-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007192036-A1 |
| priorityDate |
2002-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |